Today news
About the same in other media
Eli Lilly extends tender offer to buy Point Biopharma to Dec. 15
Reading now: 480
(Reuters) — Eli Lilly (NYSE:LLY), on Monday, gave Point Biopharma Global shareholders more time to sell their stock to the drugmaker amid low participation since the offer price was below the current stock price of the radiopharma developer.
Eli Lilly's new deadline is Dec. 15 but maintained its offer price at $12.50 per share despite it being more than 10% lower than Point's share price of $13.8 at close on Friday.
Read more on investing.comAbout this in other media
Supreme Court to deliver verdict in Article 370 case on 11 Dec livemint.com /5 months ago
Although it took a while, targeted cancer drugs lived up to the hype livemint.com /5 months ago
Elon Musk’s SpaceX valued at $175B in potential tender offer investmentnews.com /5 months ago
Show more
The website fvbb.com is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.
